ProPans-logo
ProPans-logo

Did your child recently start showing Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS/PANDAS) symptoms? Consider enrolling them in the ProPANS IVIG study.

This study will look at how well an IVIG study drug* may work for children 6 years-17 years of age who have PANS/PANDAS. Other study requirements apply.

*This drug has been FDA approved to address other conditions, but is not FDA approved for the use of addressing PANS symptoms in children.

The ProPANS study will be conducted at a select number of medical universities and institutions. For more information or to learn if your child may qualify, please contact:

Study participants receive at no cost:

  • ProPans-icon

    Access to a new IVIG study drug that may help with managing PANS/PANDAS

  • ProPans-icon

    All participants will receive the study drug and placebo (no active ingredients). Participants will be randomly assigned to receive the study drug in either the first or second half of the study

  • ProPans-icon

    Study support and study-related monitoring by a healthcare team

  • ProPans-icon

    Help with study-related travel expenses, including reimbursements for lodging, transportation, and meals

  • ProPans-icon

    Education about PANS/PANDAS

  • ProPans-icon

    The opportunity to help advance PANS/PANDAS research

Watch the video below to learn more about the ProPANS IVIG study and if your child may qualify.

Paticipating Clinical Trial Sites -

Tucson, AZ

University of Arizona

Little Rock, AR

Arkansas Children's Hospital

Boston, MA

Harvard University

Lebanon, NH

Dartmouth Hitchcock Medical Center

Centennial, CO

IMMUNOe Health Centers

Maureen Colloins
(303) 771-9000 x 1248
mcollins@immunoe.com

Los Angeles, CA

UCLA

Not sure about the trial?

If you are looking for medical care, but don't qualify for the trial. PACE partners with top universities and institutions where children affected with PANS will be appropriately treated, and where the country’s top researchers and physicians can collaborate on best practices, research, and treatment options.

A9pg9kjv_e5f9ym_7lw

Need more help?

For more information about enrollment or to find the site nearest you, please contact:

Clinical operations at Octapharma USA, Inc.

Take Action

Battling CPAE takes a dedicated team of amazing individuals all coming together for the greater good. We are grateful for any donation you are able to make.  Every dollar counts and all donations are 100% Tax Deductible.